BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 11302879)

  • 1. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Lupus; 2001; 10(12):866-72. PubMed ID: 11787876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK; Lit LC; Tam LS; Li EK; Lam CW
    Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
    Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.
    Folzenlogen D; Hofer MF; Leung DY; Freed JH; Newell MK
    Clin Immunol Immunopathol; 1997 Jun; 83(3):199-204. PubMed ID: 9175908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of costimulatory molecules in myasthenia gravis.
    Teleshova N; Matusevicius D; Kivisäkk P; Mustafa M; Pirskanen R; Link H
    Muscle Nerve; 2000 Jun; 23(6):946-53. PubMed ID: 10842273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
    Orima K; Yamazaki K; Aoyagi T; Hara K
    Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
    Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
    Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
    Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
    Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
    J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
    Spronk PE; vd Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1993 Jul; 93(1):39-44. PubMed ID: 8100746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease.
    Liu ZX; Hiwatashi N; Noguchi M; Toyota T
    Scand J Gastroenterol; 1997 Dec; 32(12):1241-6. PubMed ID: 9438323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus.
    Hu S; Tao D; He P
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):245-6, 265. PubMed ID: 15315338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.